ABBOTT LABORATORIES
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
ABT$109.93-3.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheet
(dollars in millions)
| December 31 | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $6,896 | $9,882 |
| Investments, primarily bank time deposits and U.S. treasury bills | 383 | 288 |
| Trade receivables, less allowances of — 2023: $444; 2022: $500 | 6,565 | 6,218 |
| Inventories: | ||
| Finished products | 3,946 | 3,805 |
| Work in process | 807 | 680 |
| Materials | 1,817 | 1,688 |
| Total inventories | 6,570 | 6,173 |
| Other prepaid expenses and receivables | 2,256 | 2,663 |
| Total current assets | 22,670 | 25,224 |
| Investments | 799 | 766 |
| Property and equipment, at cost: | ||
| Land | 529 | 511 |
| Buildings | 4,161 | 4,053 |
| Equipment | 15,179 | 14,164 |
| Construction in progress | 2,064 | 1,484 |
| 21,933 | 20,212 | |
| Less: accumulated depreciation and amortization | 11,779 | 11,050 |
| Net property and equipment | 10,154 | 9,162 |
| Intangible assets, net of amortization | 8,815 | 10,454 |
| Goodwill | 23,679 | 22,799 |
| Deferred income taxes and other assets | 7,097 | 6,033 |
| $73,214 | $74,438 | |
(dollars in millions)
| December 31 | ||
|---|---|---|
| 2023 | 2022 | |
| Liabilities and Shareholders’ Investment | ||
| Current liabilities: | ||
| Trade accounts payable | $4,295 | $4,607 |
| Salaries, wages and commissions | 1,597 | 1,556 |
| Other accrued liabilities | 5,422 | 5,845 |
| Dividends payable | 955 | 887 |
| Income taxes payable | 492 | 343 |
| Current portion of long-term debt | 1,080 | 2,251 |
| Total current liabilities | 13,841 | 15,489 |
| Long-term debt | 13,599 | 14,522 |
| Post-employment obligations and other long-term liabilities | 6,947 | 7,522 |
| Commitments and contingencies | ||
| Shareholders’ investment: | ||
| Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued | — | — |
| Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2023: 1,987,883,852; 2022: 1,986,519,278 | 24,869 | 24,709 |
| Common shares held in treasury, at cost — Shares: 2023: 253,807,494; 2022: 248,724,257 | (15,981) | (15,229) |
| Earnings employed in the business | 37,554 | 35,257 |
| Accumulated other comprehensive income (loss) | (7,839) | (8,051) |
| Total Abbott Shareholders’ Investment | 38,603 | 36,686 |
| Noncontrolling interests in subsidiaries | 224 | 219 |
| Total Shareholders’ Investment | 38,827 | 36,905 |
| $73,214 | $74,438 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.